Cargando…
Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines
SIMPLE SUMMARY: Cancer cachexia is a metabolic disorder that is associated with poor immunotherapeutic outcomes. However, the circulating cachexia-related cytokines have yet to be longitudinally examined to assess their role in predicting the therapeutic outcomes of PD-1/PD-L1 blockade in advanced l...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954513/ https://www.ncbi.nlm.nih.gov/pubmed/36831513 http://dx.doi.org/10.3390/cancers15041170 |